Unexpected molecular mimicry among peptides MHC class II, blood-clotting factor X, and HIV-1 envelope glycoprotein GP120

Thrombosis Research

Volumn 98, Issue 4, 2000, Pages 343-346

  Tishkoff, Garson H ^a   Hunt, Lois T ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b National Biomedical Research Foundation   (United States)

Author keywords

Factor X; HIV 1; Molecular mimicry; Vitamin K; Warfarin

Indexed keywords

BLOOD CLOTTING FACTOR 10; GLYCOPROTEIN GP 120; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS PROTEIN; WARFARIN;

AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; DISEASE RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MIMICRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; EPITOPES; FACTOR X; HIV ENVELOPE PROTEIN GP120; HIV-1; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0034658228     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00245-5     Document Type: Article

References (26)

1. Oldstone M.B.A. Molecular mimicry and autoimmune disease. Cell. 50:1987;819-820.
2. Hoxie J.A., Fitzharris T.P., Youngbar P.R.et al. Nonrandom association of cellular antigens with HTLV-III virions. Hum Immunol. 18:1987;39-52.
3. Young J.A.T. HIV and HLA similarity. Nature. 333:1988;215.
4. Vega M.A., Guigo R., Smith T.F. Autoimmune response in AIDS. Nature. 345:1990;26.
5. Golding H., Robey F.A., Gates F.T.et al. Identification of homologous regions in human immunodeficiency virus 1 gp41 and human MHC class II β1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med. 167:1988;914-923.
6. Zavitesva M.B., Moshinkov S.A., Lozhich A.T.et al. Antibodies to MHC class II peptides are present in HIV-1 positive sera. Scand J Immunol. 35:1992;267-273.
7. Hoffman G.W., Kion T.A., Grant M.D. An idiotypic network model of AIDS immunopathogenesis. Proc Natl Acad Sci USA. 88:1991;3060-3064.
8. Rothbard J.B., Taylor W.R. A sequence pattern common to T cell epitope. EMBO J. 7:1998;93-100.
9. Gasic G.P., Arenas C.P., Gasic T.B.et al. Coagulation factors X, Xa and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA. 89:1992;2317.
10. Altieri D.C., Edgington T.S. The saturable high affinity association of factor X to ATP-stimulated monocytes defines a novel function of the Mac-1 receptor. J Biol Chem. 263:1998;7007-7015.
11. Rozdinski E., Sandros J., Van-der-Flier M., Young A., Spellerberg B., Battacharyya C.et al. Inhibition of leukocyte endothelial cell interactions and inflammation by peptides from a bacterial adhesion which mimic coagulation factor X. J Clin Invest. 95:1995;1078-1085.
12. Suzuki H., Harada A., Hayashi Y.et al. Primary structure of the virus activation protease from chick embryo. Its identity with the blood clotting factor Xa. FEBS Lett. 283:1991;281-285.
13. Ogasawara T., Gotoh B., Suzuki H.et al. Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. EMBO J. 11:1992;467-472.
14. Goth B., Ogasawara T., Toyada T.et al. An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J. 9:1991;4189-4195.
15. Bost K.L., Smith E.M., Blalock J.E. Regions of complementarity between the messenger RNAs for epidermal growth factor, transferrin, interleukin-2 and their respective receptors. Biochem Biophys Res Comm. 128:1985;1373-1380.
16. Reiher W.E. III, Blalock J.E., Brunck T.K. Sequence homology between acquired imunodeficiency syndrome virus envelope protein and interleukin 2. Proc Natl Acad Sci (USA). 83:1986;9188-9192.
17. Estry D.W., Tishkoff G.H. Apparent intrinsic prothrombinase activity of human factor X zymogen. Identification with factor VIII inhibitor bypassing activity (FEIBA) Thromb Res. 36:1984;549-562.
18. Furie F., Furie B.C. Molecular and cellular biology of blood coagulation. N Engl J Med. 326:1992;800-806.
19. Williams R.K., Jiang G.-S., Snyder S.W.et al. Purification of the 100-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from the mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice. J Virol. 64:1990;3817-3823.
20. Maier R.V., Ulevitch R.J. The induction of a unique procoagulant activity in rabbit hepatic macrophages by bacterial lipopolysaccharides. J Immunol. 1127:1981;1596-1600.
21. Bourinbaiar A.S., Tax X., Nagorny R. Inhibitory effect of coumarins of HIV-1 replication and cell-free viral transmission. Acta Virol. 37:1993;241-250.
22. Lunney E.A., Hagen S.E., Domagala J.M.et al. A novel nonpeptide HIV-1 protease inhibitor. Elucidation of the binding mode and its application in the design of related analogs J Med Chem. 37:1994;2664-2677.
23. Tummino P.J., Ferguson D., Hupe D. Competitive inhibition of HIV-1 protease by warfarin derivatives. Biochem Biophys Res Comm. 201:1994;290-294.
24. Kam C.M., Fujikawa K., Powers J. Mechanism-based isocoumarin inhibitors for trypsin and blood coagulation serine protease. New anticoagulants Biochemistry. 27:1988;2547-2557.
25. Fasco M., Hildebrand T.E., Suttie J. Evidence that warfarin anticoagulant action involves two distinct reductase activities. J Biol Chem. 257:1982;11210-11212.
26. Hattori T., Koito A., Takatsuki K., Kido H., Katunuma N. Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection. FEBS Lett. 248:1989;48-52.